BORDERLINE RESECTABLE CARCINOMA

Clinical trials for BORDERLINE RESECTABLE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE RESECTABLE CARCINOMA trials appear

Sign up with your email to follow new studies for BORDERLINE RESECTABLE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Gut radiation + immunotherapy: a new hope for tough esophageal cancers?

Disease control Ongoing

This study is testing a new combination treatment for people with esophageal cancer that is difficult or impossible to remove with surgery right away. The goal is to see if adding a very low dose of radiation to the intestines to an immunotherapy and chemotherapy regimen can shri…

Matched conditions: BORDERLINE RESECTABLE CARCINOMA

Phase: PHASE2 • Sponsor: Chuangzhen Chen • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

BORDERLINE RESECTABLE CARCINOMA

Get alerted when new BORDERLINE RESECTABLE CARCINOMA trials appear

Gut radiation + immunotherapy: a new hope for tough esophageal cancers?